Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer and Merck May Benefit From Spinoffs, Goldman Sachs Says
Pfizer and Merck May Benefit From Spinoffs, Goldman Sachs Says
Pfizer and Merck May Benefit From Spinoffs, Goldman Sachs Says
Submitted by
admin
on November 30, 2011 - 2:10pm
Source:
Bloomberg
News Tags:
Pfizer
Merck
spinoff
Headline:
Pfizer and Merck May Benefit From Spinoffs, Goldman Sachs Says
Do Not Allow Advertisers to Use My Personal information
